Analysis: Series B valuations fell 50% from a $250M median in Q1 2022 to a $125M median in Q4 2022; Q4 2022's VC activity by volume resembled that of Q2 2020
Eric Newcomer / Newcomer :
Context & Ripple Effects
Eric Newcomer's analysis puts a price tag on the correction that the 2022 coverage tracked in stages: first the 23% quarter-over-quarter drop in global VC activity through June, then the 22% YoY fall in US Series A/B funding — the steepest early-stage decline since 2010 outside Q2 2020. The new data point is that the damage reached pricing itself, not just deal counts.
The full-year PitchBook/NVCA numbers already showed deal value down 30% and exit value down 91%; halving the Series B median explains why — rounds are being marked to a market where exits have largely closed. The comparison of Q4 2022 volume to Q2 2020 frames the correction as a return to pre-boom activity levels rather than a temporary dip.
First-order effects
- Founders raising Series B in late 2022 face a $125M median where $250M was standard nine months earlier — flat or down rounds are now the baseline for anyone who priced off 2021 comps.
- VCs deploying in Q4 2022 buy at half the entry valuation of Q1 2022, shifting negotiating leverage decisively toward investors on terms, not just price.
Second-order effects
- With exit value down 91% per the PitchBook/NVCA report, funds can't recycle capital through IPOs or M&A, forcing longer hold periods and leaner reserve deployment into existing portfolio companies over new Series Bs.
- The pullback cascades down the stack: Web3 funding fell 74% YoY in Q4 2022, and by Q2 2023 angel and seed deal counts had dropped roughly 50% YoY as later-stage repricing tightened the whole pipeline.
Third-order effects
- If Q4 2022's Q2-2020-like volume is the new floor rather than a trough, venture resets structurally to pre-2021 sizing — a reading the subsequent data supports, with Q1 2024 investment hitting the lowest Q1 since 2018.
- A durable 50% haircut to growth-stage marks widens the gap between private valuations and any achievable liquidity, pressuring limited partners to reprice fund commitments and pushing startups toward profitability over growth-at-all-costs.
The trend: Venture is repricing from its 2021 peak toward pre-boom baselines, with deal volume normalizing first and valuations — especially at Series B — resetting downward behind it.